Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studien
December 03, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande 3 december 2021 Immunicum tillkännager avslutad Fas Ib och tidig stängning av ILIAD-studienImmunicum AB (“Immunicum”, publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på...
Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study
December 03, 2021 02:00 ET
|
Immunicum AB
Press Release Stockholm, Sweden, December 3, 2021 Immunicum Announces Completion of Phase Ib Portion and Early Closure of ILIAD Study Immunicum AB (“Immunicum”, publ; IMMU.ST), a biopharmaceutical...
Immunicum och PCI Biotech tillkännager förlängning av sitt forskningssamarbete med att utforska nya behandlingar med cancervaccin
November 30, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande Stockholm 30 november, 2021 Immunicum och PCI Biotech tillkännager förlängning av sitt forskningssamarbete med att utforska nya behandlingar med cancervaccin Immunicum AB...
Immunicum and PCI Biotech Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments
November 30, 2021 02:00 ET
|
Immunicum AB
Press Release Stockholm, Sweden, November 30, 2021 Immunicum and PCI Biotech Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments Immunicum AB (publ;...
Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften Cells
November 22, 2021 02:00 ET
|
Immunicum AB
Pressmeddelande22 november 2021 Immunicum publicerar verkningsmekanismen för DCP-001 i tidskriften CellsImmunicum AB (publ; IMMU.ST), ett biofarmaceutiskt företag fokuserat på svårbehandlade solida...
Immunicum Publishes DCP-001 Mechanism of Action in the Journal Cells
November 22, 2021 02:00 ET
|
Immunicum AB
Press ReleaseStockholm, Sweden, November 22, 2021Immunicum Publishes DCP-001 Mechanism of Action in the Journal CellsImmunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat...
Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)
November 09, 2021 08:00 ET
|
Immunicum AB
PressmeddelandeStockholm, Sverige, 9 november 2021Immunicum presenterar nya forskningsdata vid årsmötet för Society for Immunotherapy of Cancer (SITC)Immunicum AB (publ; IMMU.ST), ett bioteknikföretag...
Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 09, 2021 08:00 ET
|
Immunicum AB
Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual MeetingImmunicum AB (publ; IMMU.ST), a biopharmaceutical...
Immunicum bjuder in till investerarmöte med bolagets VD
October 28, 2021 07:00 ET
|
Immunicum AB
Pressmeddelande 28 October 2021 Immunicum bjuder in till investerarmöte med bolagets VD Immunicum AB (publ; IMMU.ST) tillkännagav idag att bolaget måndagen den 15 november bjuder in till ett...
Immunicum to Host Investor Meeting with CEO
October 28, 2021 07:00 ET
|
Immunicum AB
Press Release 28 October 2021 Immunicum to Host Investor Meeting with CEO Immunicum AB (publ; IMMU.ST) today announced that on Monday, 15 November it will host an investor event providing the...